Cargando…
mTOR inhibitor improves testosterone-induced myocardial hypertrophy in hypertensive rats
Compelling evidence has described that the incidence of hypertension and left ventricular hypertrophy (LVH) in postmenopausal women is significantly increased worldwide. Our team’s previous research identified that androgen was an underlying factor contributing to increased blood pressure and LVH in...
Autores principales: | Chen, Jianshu, Yu, Jing, Yuan, Ruowen, Li, Ningyin, Li, Caie, Zhang, Xiaofang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859925/ https://www.ncbi.nlm.nih.gov/pubmed/34874016 http://dx.doi.org/10.1530/JOE-21-0284 |
Ejemplares similares
-
Association of free androgen index and sex hormone–binding globulin and left ventricular hypertrophy in postmenopausal hypertensive women
por: Jianshu, Chen, et al.
Publicado: (2021) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
Establishment of an Individual-Specific Nomogram for Predicting the Risk of Left Ventricular Hypertrophy in Chinese Postmenopausal Hypertensive Women
por: Yuan, Ruowen, et al.
Publicado: (2023)